CD30 is a target for therapy of Hodgkin lymphoma.33, 34 We previously reported that CD30 prestimulation by the anti‐CD30 antibody Ki‐1 enhances galectin‐1 mediated lymphoma cell apoptosis in the ALCL cell line Karpas 299.35 Western blot analysis showed that anti‐CD30 antibody stimulates upregulation of tumor necrosis factor receptor associated factor (TRAF) 1 and (inhibitor of apoptosis protein‐2) cIAP2, and downregulation of TRAF2 in Karpas 299 cells. Here, TNFRSF8 is linked to Hodgkins lymphoma.